logo
logo

OnTracx raises €1.2M in seed funding to enhance technology that aids runners in injury prevention. The investment will support their development efforts in understanding running biomechanics.

Sep 16, 20256 days ago

Amount Raised

€1.2 Million

Round Type

seed

GhentBiotechnologyHealth Care

Investors

Business AngelsKbcPmvImec.Istart Fund

Description

Ghent-based OnTracx has secured €1.2 million in seed funding to develop technology that helps runners and health professionals better understand the body’s response to running. The funding round included imec.istart fund, PMV, KBC, and a group of business angels. OnTracx is a Ghent University spin-off founded in 2023 that focuses on the global running and sports-medicine market. Their platform is designed to aid data-driven training, injury prevention, and rehabilitation for over 110 million runners worldwide.

Company Information

Company

OnTracx

Location

Ghent, East Flanders, Belgium

About

OnTracx is a Sports- and HealthTech company that works towards injury-free running, while enjoying it. Our solution offers the possibility to track load outside the traditional lab-settings, based on sensor technology. This way, OnTracx aims at preventing running injuries, or optimizing rehabilitation - with the main emphasis on gradual load progression.

Related People

Funding Insights

Based on industry data
VC-backed spending patterns
VC-backed companies spend 89% more on sales and 100% more on marketing than bootstrapped peers